19th Oct 2020 21:20
RTW Venture Fund Ltd - New York-based investment company which invests in life sciences, biopharmaceutical, and medical technology companies - Portfolio firm Tarsus Pharmaceuticals Inc prices USD88 million initial public offering on Nasdaq Global Market. Company issued 5.5 million shares at USD16.00 per share.
Tarsus is a bioopharmaceutical firm focused on the development of first-in class therapeutics for ophthalmic conditions for which there are limited treatment alternatives. On first day of trading, shares rose by 29% in value to USD20.58.
Current stock price: USD1.54
Year-to-date change: up 12%
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Rtw Biotech